S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NYSE:BMY

Bristol-Myers Squibb - BMY SEC Filings & 10K Form

$74.96
+1.16 (+1.57%)
(As of 08/9/2022 05:23 PM ET)
Add
Compare
Today's Range
$74.06
$75.51
50-Day Range
$72.12
$79.98
52-Week Range
$53.22
$80.59
Volume
8.98 million shs
Average Volume
13.81 million shs
Market Capitalization
$160.06 billion
P/E Ratio
24.90
Dividend Yield
2.93%
Price Target
$75.57

Recent Bristol-Myers Squibb SEC Filings

DateFilerForm TypeView
08/09/2022
6:00 AM
Bristol-Myers Squibb (Filed by)
Turning Point Therapeutics, Inc. (Subject)
Form SC TO-T/A
07/27/2022
10:01 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2022
6:44 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2022
6:13 AM
Bristol-Myers Squibb (Filed by)
Turning Point Therapeutics, Inc. (Subject)
Form SC TO-T/A
07/05/2022
3:31 PM
Bristol-Myers Squibb (Issuer)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:31 PM
Bristol-Myers Squibb (Issuer)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2022
3:42 PM
Bristol-Myers Squibb (Filed by)
Turning Point Therapeutics, Inc. (Subject)
Form SC TO-T
06/16/2022
5:09 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:08 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/16/2022
9:40 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/16/2022
9:39 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/16/2022
9:37 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/15/2022
3:29 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2022
4:58 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2022
4:50 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2022
4:49 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2022
4:15 PM
Bristol-Myers Squibb (Filed by)
Turning Point Therapeutics, Inc. (Subject)
Form SC TO-C
05/04/2022
6:32 PM
Bristol-Myers Squibb (Issuer)
Greenlees Sharon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/04/2022
6:29 PM
Bristol-Myers Squibb (Issuer)
Greenlees Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
9:47 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2022
6:42 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2022
3:30 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/18/2022
3:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2021
4:51 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
3:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2021
9:37 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/28/2021
6:33 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2021
4:18 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
4:17 PM
BONNEY MICHAEL W (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:42 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/16/2021
1:41 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/16/2021
1:39 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/15/2021
4:14 PM
Bristol-Myers Squibb (Issuer)
Weese Michelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2021
5:56 PM
BONNEY MICHAEL W (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
5:56 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:37 PM
BONNEY MICHAEL W (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:36 PM
Bristol-Myers Squibb (Issuer)
Eid Joseph (Reporting)
6-K - Bank of N.T. Butterfield & Son Ltd (Filer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:35 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
3:43 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
3:34 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/20/2021
3:32 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
3:39 PM
Bristol-Myers Squibb (Issuer)
Schmukler Louis S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
3:38 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:56 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
3:55 PM
Bristol-Myers Squibb (Filer)
Form S-8 POS
04/29/2021
9:08 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2021
7:38 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2021
6:41 AM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/12/2021
4:29 PM
Bristol-Myers Squibb (Subject)
Mercy Investment Services, Inc. (Filed by)
Form PX14A6G
04/05/2021
4:28 PM
Bristol-Myers Squibb (Filed by)
SUTRO BIOPHARMA, INC. (Subject)
Form SC 13G/A
04/05/2021
4:27 PM
Bristol-Myers Squibb (Filed by)
IDEAYA Biosciences, Inc. (Subject)
Form SC 13G/A
04/05/2021
4:26 PM
AGIOS PHARMACEUTICALS, INC. (Subject)
Bristol-Myers Squibb (Filed by)
Form SC 13D/A
04/05/2021
4:26 PM
Bristol-Myers Squibb (Filed by)
Jounce Therapeutics, Inc. (Subject)
Form SC 13G/A
04/05/2021
4:25 PM
Bristol-Myers Squibb (Filed by)
Ikena Oncology, Inc. (Subject)
Form SC 13G
04/02/2021
12:23 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:22 PM
BERTOLINI ROBERT J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:20 PM
BONNEY MICHAEL W (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:18 PM
Bristol-Myers Squibb (Issuer)
Emmens Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:16 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:14 PM
Bristol-Myers Squibb (Issuer)
Mily Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:13 PM
Bristol-Myers Squibb (Issuer)
Paliwal Dinesh C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:10 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:09 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:08 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:07 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:06 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2021
3:41 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:59 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:59 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:59 PM
Bristol-Myers Squibb (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:58 PM
Bristol-Myers Squibb (Issuer)
Eid Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:57 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:56 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:52 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:51 PM
Bristol-Myers Squibb (Issuer)
Mily Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:51 PM
Bristol-Myers Squibb (Issuer)
Powell Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:50 PM
Bristol-Myers Squibb (Issuer)
Santiago Karen Murphy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:50 PM
Bristol-Myers Squibb (Issuer)
Schmukler Louis S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:50 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
5:50 PM
Bristol-Myers Squibb (Issuer)
von Autenried Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
3:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2021
4:27 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:26 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
4:00 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
9:00 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
3:42 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
2:13 PM
Bristol-Myers Squibb (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/08/2021
6:29 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2021
6:29 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2021
6:28 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
3:36 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
7:04 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
6:20 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:19 PM
Bristol-Myers Squibb (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:19 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:18 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:18 PM
BERTOLINI ROBERT J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:18 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:17 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:17 PM
Bristol-Myers Squibb (Issuer)
Emmens Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NYSE:BMY) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.